Diagnamed Holdings Corp. (DMED.CN) Comparison with companies in other sectors?

Diagnamed Holdings Corp. has a share price of 83.41M. You can analyze Diagnamed Holdings Corp. (DMED.CN) competitors across different market sectors through stock heatmaps.

What are DMED.CN's NET and operating margins?

Diagnamed Holdings Corp. (DMED.CN) operating margin is around 0.00, and net profit margin is approximately 0.00 as of the latest reports.

In what way does DMED.CN's earnings per share (EPS) trend reflect its financial momentum?

Diagnamed Holdings Corp. (DMED.CN) EPS is -0.01 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Diagnamed Holdings Corp. is -5.50, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Diagnamed Holdings Corp.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Diagnamed Holdings Corp. like P/E which is -5.82, P/B which is -15.62, and PEG which is 0.41. Compare them with sector averages to evaluate if the stock is priced fairly.

Diagnamed Holdings Corp.

DMED.CN•CNQ

Healthcare

Medical - Healthcare Information Services

CA$0.06

CA$0.005(9.09%)

Diagnamed Holdings Corp. (DMED.CN) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.01

P/E Ratio

-5.50

ROE

6.54%

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$4.59M

Shares OutstandingTotal number of shares issued

$83.41M

Book Value/ShareNet worth per share

$-0.00

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.01

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

654.24%

ROAReturn on total assets

-479.30%

ROCEReturn on capital employed

223.33%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.00

Cash/ShareCash and equivalents per share

$0.001

FCF YieldFree cash flow as percentage of market cap

-7.65%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for DMED.CNFinancial Ratios Analysis details for DMED.CN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for DMED.CNSector Benchmarking details for DMED.CN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Diagnamed Holdings Corp. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Diagnamed Holdings Corp.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Diagnamed Holdings Corp.'s unique business strengths and challenges.

Key Financial Metrics for Diagnamed Holdings Corp.

For Diagnamed Holdings Corp., essential financial indicators include EPS -0.01, PE -5.50, and ROE 6.54. These key ratios reveal insights into Diagnamed Holdings Corp.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Diagnamed Holdings Corp. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Diagnamed Holdings Corp.

Metrics like Net Margin - and ROA -479.30% shed light on how well Diagnamed Holdings Corp. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Diagnamed Holdings Corp. can sustain its operations and continue growing in the future.

Valuation and Market Position of Diagnamed Holdings Corp.

Using ratios such as P/B Ratio -15.62 and PEG Ratio 0.41, investors can assess whether Diagnamed Holdings Corp. is appropriately valued based on its financials and growth potential. These figures, combined with Diagnamed Holdings Corp.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Diagnamed Holdings Corp.

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow $-0.00, provide a snapshot of Diagnamed Holdings Corp.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Diagnamed Holdings Corp., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Diagnamed Holdings Corp.

Investing in Diagnamed Holdings Corp. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Diagnamed Holdings Corp. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;